ArticleFrontiers in public health2026
The trajectories of cardiometabolic multimorbidity associate with mortality risk: a study based on Guangdong adult chronic diseases and risk factors cohort.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiometabolic multimorbidity (CMM) prevalence has risen, but longitudinal evidence on trajectories and mortality links remains limited. Objective: This study aimed to examine CMM trends and the impact of its statuses/trajectories on mortality in Guangdong, China. Design: This is a cohort study. Setting: Data were collected from the Guangdong Provincial adult chronic diseases and risk factors cohort (GDACRC). The follow-up data were collected from the hospitalization record system and the vital register system in Guangdong Province. Participants: Baseline surveys were separately conducted in 2007, 2010, 2013, 2015, and 2018, which recruited 34,244 participants aged 18 years or older. Measurements: Calculated age-sex standardized CMM prevalence. Cox proportional hazards models were used to assess the associations between CMM statuses/trajectories and mortality risk. Results: From 2007 to 2018, the prevalence of CMM increased significantly from 4.31 to 8.75% in Guangdong Province, China ( Limitation: Single-province sample; self-report bias. Conclusion: CMM represents a major public health challenge in Guangdong Province, China. Our findings provide new insights on the CMM progression, which may be helpful for prevention and clinical management of CMM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.